ACI’s 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities

Partner Laurie A. Burlingame will speak at the American Conference Institute’s 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities.

Laurie will participate in the panel The Launch Trajectory of a Novel Therapeutic: Developing a Blueprint for Success taking place on Thursday, March 21, from 3:00–4:00 pm. Panelists will use case study examples to analyze the trajectory of a novel therapeutic’s journey from concept to commercial approval. The panel will provide insights into the strategic, regulatory, and market factors that converge to catapult a novel therapeutic from the lab to the patient.

Topics will include:

• Identifying key research and development milestones that lay the foundation for a successful launch
• Insights into effective engagement with the regulatory agencies to streamline the approval process
• Strategizing to overcome market access barriers
• Examining the ongoing efforts for market expansion post-launch, including lifecycle management and broadening of indications